IL126431A - Enteric-coated pharmaceutical compositions of mycophenolate - Google Patents

Enteric-coated pharmaceutical compositions of mycophenolate

Info

Publication number
IL126431A
IL126431A IL12643197A IL12643197A IL126431A IL 126431 A IL126431 A IL 126431A IL 12643197 A IL12643197 A IL 12643197A IL 12643197 A IL12643197 A IL 12643197A IL 126431 A IL126431 A IL 126431A
Authority
IL
Israel
Prior art keywords
mycophenolate
enteric
pharmaceutical compositions
coated pharmaceutical
coated
Prior art date
Application number
IL12643197A
Other languages
English (en)
Other versions
IL126431A0 (en
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL126431(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9607564.3A external-priority patent/GB9607564D0/en
Priority claimed from GBGB9622028.0A external-priority patent/GB9622028D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL126431A0 publication Critical patent/IL126431A0/xx
Publication of IL126431A publication Critical patent/IL126431A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
IL12643197A 1996-04-12 1997-04-10 Enteric-coated pharmaceutical compositions of mycophenolate IL126431A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9607564.3A GB9607564D0 (en) 1996-04-12 1996-04-12 Organic compounds
GBGB9622028.0A GB9622028D0 (en) 1996-10-24 1996-10-24 Organic compounds
PCT/EP1997/001800 WO1997038689A2 (en) 1996-04-12 1997-04-10 Enteric-coated pharmaceutical compositions of mycophenolate

Publications (2)

Publication Number Publication Date
IL126431A0 IL126431A0 (en) 1999-08-17
IL126431A true IL126431A (en) 2005-03-20

Family

ID=26309105

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12643197A IL126431A (en) 1996-04-12 1997-04-10 Enteric-coated pharmaceutical compositions of mycophenolate

Country Status (34)

Country Link
US (3) US6025391A (nl)
EP (2) EP0892640B1 (nl)
JP (2) JP3779732B2 (nl)
CN (1) CN1104238C (nl)
AR (2) AR006583A1 (nl)
AT (2) ATE259228T1 (nl)
AU (1) AU725388B2 (nl)
BE (1) BE1010963A3 (nl)
BR (1) BR9708624A (nl)
CO (1) CO4900024A1 (nl)
CY (1) CY2243B1 (nl)
CZ (1) CZ291811B6 (nl)
DE (4) DE19781690D2 (nl)
DK (1) DK0892640T3 (nl)
ES (2) ES2216141T3 (nl)
FR (1) FR2747920B1 (nl)
GB (1) GB2326339B (nl)
GR (1) GR1002893B (nl)
HK (2) HK1016490A1 (nl)
HU (1) HU224919B1 (nl)
ID (1) ID18663A (nl)
IE (1) IE970267A1 (nl)
IL (1) IL126431A (nl)
IT (1) IT1297045B1 (nl)
LU (1) LU91094I2 (nl)
MY (1) MY119049A (nl)
NL (1) NL300157I2 (nl)
NO (2) NO322891B1 (nl)
NZ (1) NZ332117A (nl)
PT (1) PT892640E (nl)
RU (2) RU2615397C2 (nl)
TR (1) TR199802056T2 (nl)
TW (1) TW457098B (nl)
WO (1) WO1997038689A2 (nl)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE474590T1 (de) * 1999-05-10 2010-08-15 Paolo Brenner Kombination von immunsuppressiven substanzen zur behandlung oder vorbeugung von transplantat abstossungen
US20030050692A1 (en) * 2000-12-22 2003-03-13 Avantec Vascular Corporation Delivery of therapeutic capable agents
GB0124953D0 (en) * 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
PL206018B1 (pl) * 2001-10-19 2010-06-30 Isotechnika Inc Preparat farmaceutyczny, sposób jego wytwarzania, mikroemulsja i zastosowanie tego preparatu farmaceutycznego
GB0301259D0 (en) 2003-01-20 2003-02-19 Novartis Ag Organic compounds
GB0314553D0 (en) * 2003-06-21 2003-07-30 Weatherford Lamb Electric submersible pumps
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
ES2314646T3 (es) * 2004-03-22 2009-03-16 Solvay Pharmaceuticals Gmbh Composiciones farmaceuticas por via de productos que contienen lipasa , en particular de pancreatina, que contienen tensioactivos.
WO2005105768A2 (en) * 2004-04-26 2005-11-10 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Process for preparation of mycophenolic acid and ester derivatives thereof
US20050250773A1 (en) 2004-04-27 2005-11-10 Sandor Molnar Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
EP1908756A1 (en) * 2004-07-20 2008-04-09 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Processes for preparation of crystalline mycophenolate sodium
GB0419355D0 (en) * 2004-08-31 2004-09-29 Novartis Ag Organic compounds
US20060235009A1 (en) * 2005-02-08 2006-10-19 Richard Glickman Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
US20060235070A1 (en) * 2005-02-08 2006-10-19 Hayden Michael R Compositions and methods for treating vascular, autoimmune, and inflammatory diseases
BRPI0614914A2 (pt) 2005-07-29 2011-04-19 Solvay Pharm Gmbh processos para a fabricação de pó de pancreatina esterilizada
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
CN1985994B (zh) * 2005-12-19 2011-01-12 康泰乐(北京)医药科技发展有限公司 改进的包含霉酚酸盐的包有肠溶衣的药物组合物
EP1988890A1 (en) * 2006-02-13 2008-11-12 Novartis AG High dosage of mycophenolic acid (mpa)
JP2007230948A (ja) * 2006-03-02 2007-09-13 Univ Meijo 腸溶性化硬カプセル
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
DK2032712T3 (da) * 2006-06-29 2010-05-25 Ivax Pharmaceuticals Sro Regulering af syremetabolitproduktion
US20080182998A1 (en) * 2007-01-25 2008-07-31 Apotex Fermentation Inc. Novel crystalline mycophenolate sodium polymorph and processes to manufacture same
US20080176937A1 (en) * 2007-01-23 2008-07-24 Apotex Fermentation Inc. Novel crystalline mycophenolate sodium polymorph and processes to manufacture same
MX2008015797A (es) * 2007-04-11 2009-03-06 Teva Gyogyszergyar Zartkoeruen Metodo para reducir el nivel de impurezas en la fermentacion del acido micofenolico.
MX2010001711A (es) * 2007-08-13 2010-03-11 Panacea Biotec Ltd Composiciones de liberacion extendida que comprenden micofenolato sodico y procedimientos de las mismas.
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
CN102099029A (zh) * 2008-07-09 2011-06-15 阿斯普瑞瓦国际公司 治疗眼部病症的霉酚酸钠的pH值特定溶液
US20110086102A1 (en) * 2009-10-13 2011-04-14 Teva Pharmaceutical Industries Ltd. Delayed release compositions
EP2488173A1 (en) * 2009-10-13 2012-08-22 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011051967A2 (en) * 2009-10-23 2011-05-05 Alkem Laboratories Ltd Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
CN103880800A (zh) * 2010-11-16 2014-06-25 北京京卫信康医药科技发展有限公司 麦考酚酸钠的新晶型及其制备方法
CN103880799A (zh) * 2010-11-16 2014-06-25 北京京卫信康医药科技发展有限公司 麦考酚酸钠的新晶型及其制备方法
GB201100786D0 (en) 2011-01-18 2011-03-02 Ems Sa Pharmaceutical compositions of immunosuppressants
WO2013041205A1 (de) 2011-09-19 2013-03-28 Pyxirion Pharma Gmbh Neue therapeutische konzepte zur behandlung von gefässerkrankungen
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
NZ741985A (en) 2013-03-14 2019-12-20 Alkermes Pharma Ireland Ltd Prodrugs of fumarates and their use in treating various diseases
WO2014167442A1 (en) 2013-03-26 2014-10-16 Wockhardt Limited Pharmaceutical compositions comprising mycophenolic acid or salts thereof
WO2015101971A1 (en) 2014-01-06 2015-07-09 Iron Therapeutics Holdings Ag Dosage regimen of ferric trimaltol
CA2940845C (en) 2014-02-24 2019-09-24 Alkermes Pharma Ireland Limited Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen
US10213411B2 (en) 2015-08-27 2019-02-26 Vijaykumar Rajasekhar Use of prodrugs of fumarates in treating heart failure diseases
US10463642B2 (en) 2016-02-01 2019-11-05 Vijaykumar Rajasekhar Methods of treating heart failure diseases using prodrugs of methyl hydrogen fumarate
BR112019019003A2 (pt) 2017-03-13 2020-04-14 Okava Pharmaceuticals Inc métodos e composições para dispensação de agentes ativos de ácidos micofenólicos a mamíferos não humanos
IL305524A (en) 2021-03-03 2023-10-01 Sana Biotechnology Inc Immunosuppressive treatments for use with cardiomyocyte cell treatments, and associated methods and preparations
CN114028334B (zh) * 2021-12-10 2023-08-29 卓和药业集团股份有限公司 一种肺部给药的免疫抑制剂的制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157100A (en) * 1966-09-27 1969-07-02 Ici Ltd Pharmaceutical Compositions
GB1157099A (en) * 1966-09-27 1969-07-02 Ici Ltd Fermentation Process
GB1173942A (en) * 1967-06-06 1969-12-10 Bellon Labor Sa Roger New 2,3-Dihydro-1,4-Benzoxazines
GB1158387A (en) * 1967-06-13 1969-07-16 Ici Ltd Procedure for Isolation of Mycophenolic Acid
GB1203328A (en) * 1968-06-04 1970-08-26 Ici Ltd Pharmaceutical compositions
GB1261060A (en) * 1969-09-09 1972-01-19 Ici Ltd Phthalen-1-one derivatives
US3705946A (en) * 1971-05-25 1972-12-12 Lilly Co Eli Method of treating hyperuricemia
US3825571A (en) * 1971-07-31 1974-07-23 Chugai Pharmaceutical Co Ltd Mycophenolic acid derivatives
JPS5542995B2 (nl) * 1972-02-24 1980-11-04
US3868454A (en) * 1972-08-14 1975-02-25 Lilly Co Eli Psoriasis treatment with mycophenolic acid derivatives
US3777020A (en) * 1972-08-14 1973-12-04 Lilly Co Eli Psoriasis treatment with mycophenolic acid
US4005108A (en) * 1973-04-03 1977-01-25 Research Corporation Novel anti-leukemic diterpenoid triepoxides
US3880995A (en) * 1973-05-14 1975-04-29 Lilly Co Eli Treatment of arthritis with mycophenolic acid and derivatives
US3903071A (en) * 1973-05-22 1975-09-02 Lilly Co Eli Mycophenolic acid derivatives
JPS517116A (en) * 1974-06-11 1976-01-21 Shinetsu Chemical Co Choyoseihifukuyakuzaino seizohoho
US4234684A (en) * 1979-12-11 1980-11-18 Eli Lilly And Company Method of preparing mycophenolic acid glucoside
IT1150194B (it) * 1982-02-23 1986-12-10 Chiesi Farma Spa Formulazioni farmaceutiche ad attivita'antiinfiammatoria, analgesica,antipiretica e gastroprotettiva
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
US4686234A (en) * 1985-11-27 1987-08-11 Syntex (U.S.A) Inc. Mycophenolic acid derivatives in the treatment of inflammatory diseases, in particular rheumatoid arthritis
US4959387A (en) * 1986-01-23 1990-09-25 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4727069A (en) * 1987-01-30 1988-02-23 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid, derivatives thereof and pharmaceutical compositions
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US4847381A (en) * 1987-08-31 1989-07-11 American Cyanamid Company 2-Phenyl-4-quinoline carboxylic acids
US5135934A (en) * 1990-07-06 1992-08-04 Du Pont Merck Pharmaceutical Company 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents
US5372298A (en) * 1992-01-07 1994-12-13 The Regents Of The University Of California Transient liquid phase ceramic bonding
CA2086642C (en) * 1992-01-09 2004-06-15 Randall E. Morris Method of treating hyperproliferative vascular disease
US5516781A (en) * 1992-01-09 1996-05-14 American Home Products Corporation Method of treating restenosis with rapamycin
US5283257A (en) * 1992-07-10 1994-02-01 The Board Of Trustees Of The Leland Stanford Junior University Method of treating hyperproliferative vascular disease
AU6826194A (en) * 1993-05-06 1994-12-12 Pharmagenesis, Inc. 16-hydroxytriptolide composition and method for immunotherapy
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
ES2248793T3 (es) * 1993-10-01 2006-03-16 Roche Palo Alto Llc Suspensiones orales de alta dosis de mofetil micofenolato.
WO1995013082A1 (en) * 1993-11-08 1995-05-18 Pharmagenesis, Inc. Immunotherapy composition and method
CA2175215C (en) * 1993-11-19 2008-06-03 Yat Sun Or Semisynthetic analogs of rapamycin (macrolides) being immunomodulators

Also Published As

Publication number Publication date
HUP9903373A3 (en) 2001-05-28
NO2007004I2 (no) 2009-10-19
DE69727559T2 (de) 2004-12-16
NO2007004I1 (no) 2007-04-16
DE122004000038I2 (de) 2006-04-27
ES2178510A1 (es) 2002-12-16
WO1997038689A2 (en) 1997-10-23
ATA905997A (de) 2001-04-15
NO322891B1 (no) 2006-12-18
FR2747920A1 (fr) 1997-10-31
ATE259228T1 (de) 2004-02-15
CY2243B1 (en) 2003-07-04
WO1997038689A3 (en) 1997-12-04
PT892640E (pt) 2004-06-30
US6172107B1 (en) 2001-01-09
NO984728D0 (no) 1998-10-09
JP2006063086A (ja) 2006-03-09
EP0892640B1 (en) 2004-02-11
CZ291811B6 (cs) 2003-06-18
AT408415B (de) 2001-11-26
ES2178510B1 (es) 2004-08-16
US6306900B1 (en) 2001-10-23
HK1051484A1 (zh) 2003-08-08
GB9821304D0 (en) 1998-11-25
DE122004000038I1 (de) 2006-01-26
TW457098B (en) 2001-10-01
AR059693A2 (es) 2008-04-23
NL300157I1 (nl) 2004-10-01
BE1010963A3 (fr) 1999-03-02
LU91094I2 (fr) 2004-10-11
AU725388B2 (en) 2000-10-12
CN1215991A (zh) 1999-05-05
HUP9903373A2 (hu) 2001-04-28
ES2216141T3 (es) 2004-10-16
ITRM970207A1 (it) 1998-10-11
GB2326339A (en) 1998-12-23
RU2615397C2 (ru) 2017-04-04
GB2326339B (en) 2000-04-19
EP0892640A2 (en) 1999-01-27
AU2384397A (en) 1997-11-07
FR2747920B1 (fr) 1999-12-31
JP2000503665A (ja) 2000-03-28
RU2203659C2 (ru) 2003-05-10
CN1104238C (zh) 2003-04-02
CZ326798A3 (cs) 1999-01-13
AR006583A1 (es) 1999-09-08
BR9708624A (pt) 1999-08-03
NL300157I2 (nl) 2004-12-01
IL126431A0 (en) 1999-08-17
NZ332117A (en) 2000-04-28
DK0892640T3 (da) 2004-05-10
US6025391A (en) 2000-02-15
IE970267A1 (en) 1997-10-22
MY119049A (en) 2005-03-31
DE69727559D1 (de) 2004-03-18
EP1221316A1 (en) 2002-07-10
ID18663A (id) 1998-04-30
DE19781690D2 (de) 1999-04-08
NO984728L (no) 1998-12-02
JP3779732B2 (ja) 2006-05-31
TR199802056T2 (xx) 1999-02-22
GR1002893B (el) 1998-04-10
CO4900024A1 (es) 2000-03-27
HK1016490A1 (en) 1999-11-05
IT1297045B1 (it) 1999-08-03
HU224919B1 (en) 2006-04-28

Similar Documents

Publication Publication Date Title
GB2326339B (en) Enteric-coated pharmaceutical compositions of mycophenolate
HUP0002183A3 (en) Pharmaceutical composition for combination of piperidinoalkanol-decongestant
EG24118A (en) Pharmaceutical compositions
GB9508791D0 (en) Compositions of matter
ZA9710006B (en) Novel pharmaceutical compositions
GB9616672D0 (en) Pharmaceutical compositions
GB9610359D0 (en) Pharmaceutical compositions
EG24294A (en) Pharmaceutical compositions
GB9506382D0 (en) Pharmaceutical compositions
ZA96525B (en) Novel pharmaceutical compositions
GB9622681D0 (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
GB9613457D0 (en) Pharmaceutical compositions
SI0892640T1 (en) Enteric-coated pharmaceutical compositions of mycophenolate
GB9618376D0 (en) Pharmaceutical compositions
GB9610136D0 (en) Pharmaceutical compositions
GB9510222D0 (en) Compositions of matter
GB9712031D0 (en) Compositions of matter
GB9709824D0 (en) Compositions of matter
GB9426218D0 (en) Processes of preparing pharmaceutical compositions
GB9426196D0 (en) Processes of preparing pharmaceutical compositions
GB9623225D0 (en) Novel pharmaceutical compositions
ZA973116B (en) Enteric coated pharmaceutical composition
HUP0003666A3 (en) Method for the preparation of citalopram and pharmaceutical compositions containing them
SI0941095T1 (en) Improved pharmaceutical compositions

Legal Events

Date Code Title Description
EXTP Application for extension order is pending
FF Patent granted
KB Patent renewed
EXTN Extension order renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXTN Extension order renewed
EXTN Extension order renewed